Securing a partner to serve as an extension of Janssen’s Biotherapeutics Development API-Large Molecule team was essential to reducing both risk and the time needed for delivery of critical clinical supplies.
By applying remote monitoring solutions, advanced modeling, and optimization of manufacturing processes, Industry 4.0 offers improved process reliability and product quality through unlimited possibilities of connecting machines and data.
Companies must understand how today’s new pharmaceutical landscape is causing a dramatic shift in how we plan for and execute drug development and manufacturing.
Vaccines are absolutely crucial for maintaining global health, but are a challenge to develop and manufacture. How can businesses ensure profitability while providing low prices for developing countries?
The biosimilars market is suddenly booming, with established biopharma giants and nimble start-ups all clamoring for a piece of the action. But such steep competition means that only the wise will survive.
Bypassing conventional trial-and-error methods for solubility challenges and excipient selection can eliminate unnecessary testing, improve the efficacy of formulations, and increase overall speed to market.
Watch this video to learn more about this manufacturing site capabilities, quality management systems, PPI implementation, product expansion, assurance of supply and lead times.
OptiForm® Solution Suite is a comprehensive offering which incorporates everything you need to progress your candidate from late-stage discovery to phase I.
A platform that combines drug development expertise and biomanufacturing and integrated services to offer advantages to ADC developers.
This webinar explores use cases showing how machine learning and analytics can help overcome the challenges facing the biopharma industry through more confident data-driven decisions.
Striving to bring the way we acquire, share and gain insights from scientific data, through a community and the framework for standardization and linked data.
With transformational changes in biologics, there are increasingly newer formats of new biologic drugs including bispecific antibodies, antibody drug conjugates and antibody-peptide fusion proteins.
Nitto Avecia Pharma Services is a CGMP contract development and manufacturing organization. Avecia Pharma's experienced and knowledgeable formulation team can reduce product risk and accelerate the drug development process by providing you with the optimum dosage form selection.
Nitto Avecia Pharma Services has in-depth experience with a wide range of drug delivery device technologies to offer your programs comprehensive technical support.
Culturing in a Thermo Scientific™ Nunc™ Cell Factory™ system is as simple as culturing in T-flask or dish. Seed the Cell Factory system with the same medium and cell density (cells/cm2) as in a flask or dish. A volume of 150-200 mL per tray (2.4 - 3.2mm depth) is commonly used. Simply identify the size of the Cell Factory system you are using in the chart below and apply the suggested working volumes for each step of the cell culturing process."
